Linda Härmark has more than 15 years experience in the field of pharmacovigilance and currently holds the position of deputy director of the Netherlands Pharmacovigilance Centre Lareb. She is/has been the Lareb lead participants in international projects such as IMI WEB-RADR and Conception project and the EDCTP PAVIA project. Her main research area is patient involvement in pharmacovigilance and the use of web-based intensive monitoring to gather information about ADRs . She has published more than 40 peer-reviewed papers in the field of pharmacovigilance.
